Market Overview

UPDATE: Barclays Initiates Coverage On Rexnord, Raises Estimates

Related RXN
Barclays Upgrades US Multi-Industry Names, Sees Long-Term Plays If Traders Buy The Dip
Earnings Scheduled For August 1, 2016
Barclays turns more optimistic on industrials, especially 3M (Seeking Alpha)

In a research note released Wednesday, Barclays analyst Scott R. Davis initiated coverage on Rexnord (NASDAQ: RXN) with an Overweight rating and a price target of $37.00.

The company is raising its earnings per share estimates to $1.70 from $1.65; the firm is also raising its 2016 estimates to $2.15 from $1.75.

The firm said that the timing of this report comes on the increased confidence in Rexnord's ability to execute on M&A and also drive up higher-than-expected operating leverage.

Barclays also stated that Rexnord has a strong operating foundation. It also stated, "In 2018, for example (calendar 2017), RXN thinks it has earnings potential in the ~$3 range, we see potential above that ($3.50-4.00 range)."

Shares of Rexnord closed at $27.14, up 4.99 percent.

Latest Ratings for RXN

Oct 2016BarclaysUpgradesEqual-WeightOverweight
Jul 2016BarclaysMaintainsEqual-Weight
Jun 2016BairdDowngradesOutperformNeutral

View More Analyst Ratings for RXN
View the Latest Analyst Ratings

Posted-In: Barclays Scott R. DavisAnalyst Color Guidance Initiation Analyst Ratings


Related Articles (RXN)

View Comments and Join the Discussion!